Company Search:
Advanced Search
Sponsored Links
Xiangxue Pharmaceutical Co Ltd Company Snapshot
Xiangxue Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xiangxue Pharmaceutical Co Ltd with three other companies in this sector in China: Guilin Sanjin Pharmaceutical Co Ltd (2015 sales of 1.37 billion Chinese Renmimbi [US$203.50 million] of which 96% was Proprietary Chinese medicine), Shanghai Kaibao Pharmaceutical Company Limited (1.40 billion Chinese Renmimbi [US$207.04 million] of which 100% was Industrial), and Anhui Fengyuan Pharmaceutical (1.55 billion Chinese Renmimbi [US$230.50 million] of which 59% was Medicine Retail Circulation).

Sales Analysis. During the year ended December of 2015, sales at Xiangxue Pharmaceutical Co Ltd were 1.46 billion Chinese Renmimbi (US$217.12 million). This is a decrease of 3.9% versus 2014, when the company's sales were 1.52 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 18.8% decline in Medical Apparatus and Instruments, from 45.01 million Chinese Renmimbi to 36.53 million Chinese Renmimbi. There were also decreases in sales in Pharmaceutical Manufacturing (down 10.0% to 775.54 million Chinese Renmimbi) and Pharmaceutical Distribution (down 9.9% to 158.66 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Chinese Herbal Medicines (up 15.4% to 395.26 million Chinese Renmimbi) and Beverage (up 15.2% to 84.61 million Chinese Renmimbi) and Other Operations (up 13.2% to 14.01 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xiangxue Pharmaceutical Co Ltd
  Stock Performance Chart for Xiangxue Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 14.21
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 1.7%  
4 Weeks -5.1%   52 Weeks -34.2%  
Xiangxue Pharmaceutical Co Ltd Key Data:
  Ticker: 300147 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,463,569,959
(Year Ending Jan 2016).
Employees: 3,018
  Currency: Chinese Renmimbi Market Cap: 9,399,578,720
  Fiscal Yr Ends: December Shares Outstanding: 661,476,335
  Share Type: A Gu Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.